The nuclear transcription factor κB/bcl-2 pathway correlates with pathologic complete response to doxorubicin-based neoadjuvant chemotherapy in human breast cancer

Thomas A. Buchholz*, Amit K. Garg, Nitin Chakravarti, Bharat B. Aggarwal, Francisco J. Esteva, Henry M. Kuerer, S. Eva Singletary, Gabriel N. Hortobagyi, Lajos Pusztai, Massimo Cristofanilli, Aysegul A. Sahin

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

78 Scopus citations

Fingerprint

Dive into the research topics of 'The nuclear transcription factor κB/bcl-2 pathway correlates with pathologic complete response to doxorubicin-based neoadjuvant chemotherapy in human breast cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences